(Allergan plc)

	AGN latest price $301.4400 (1.65%) ($297.3380 - $301.9418) on Tue. Jun. 23, 2015.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.26% (three month average)
RSI	55
Latest Price	$301.4400(1.65%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 1% a day on average for past five trading days.
Weekly Trend	AGN advances 0.6% a week on average for past two weeks.
Market Behavior	Value stock rally for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   XLV(54%)    IBB(53%)    XBI(47%)    SPY(43%)    VT(42%)
Factors Impacting AGN price	AGN will decline at least -0.63% in a week (0% probabilities).   VIXM(-31%)    TLT(-19%)    SHY(-7%)    UUP(-6%)    IGOV(-5%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.63% (StdDev 1.26%)
Hourly BBV	0 ()
Intraday Trend	1.3%

5 Day Moving Average	$294.03(2.52%)
10 Day Moving Average	$292.11(3.19%)
20 Day Moving Average	$293.03(2.87%)
To recent high	-0.8%
To recent low	10.4%
Market Cap	$99.385b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed